kw.\*:("Dopamina antagonista")
Results 1 to 25 of 224
Selection :
SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphineMEREU, G; COLLU, M; ONGINI, E et al.European journal of pharmacology. 1985, Vol 111, Num 3, pp 393-396, issn 0014-2999Article
Effect of haloperidol on dopamine-induced increase in renal blood flowARMSTRONG, D. K; DASTA, J. F; REILLEY, T. E et al.Drug intelligence & clinical pharmacy. 1986, Vol 20, Num 7-8, pp 543-546, issn 0012-6578Article
[3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptorsPORCEDDU, M. L; ONGINI, E; BIGGIO, G et al.European journal of pharmacology. 1985, Vol 118, Num 3, pp 367-370, issn 0014-2999Article
BRL 20596, a novel anilide with central dopamine antagonist activityCAMPBELL, W; CLARK, M. S. G; MITCHELL, P. J et al.Psychopharmacologia. 1986, Vol 89, Num 2, pp 208-215, issn 0033-3158Article
Bilateral ballistic movements occuring as a late complication of hemispherectomy and responding to sulpirideWROE, S; RICHENS, A; COMPSTON, A et al.Journal of neurology. 1986, Vol 233, Num 5, pp 315-316, issn 0340-5354Article
Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activityLAURSEN, A. L; GERLACH, J.Acta psychiatrica Scandinavica. 1986, Vol 73, Num 1, pp 17-21, issn 0001-690XArticle
Remoxipride in the treatment of acute maniaCHOUINARD, G; STEINER, W.Biological psychiatry (1969). 1986, Vol 21, Num 14, pp 1429-1433, issn 0006-3223Article
D-1 dopamine receptor stimulation elevates plasma prolactin levelsSALLER, C. F; SALAMA, A. I.European journal of pharmacology. 1986, Vol 122, Num 1, pp 139-142, issn 0014-2999Article
Domperidone and Parkinson's diseasePARKES, J. D.Clinical neuropharmacology. 1986, Vol 9, Num 6, pp 517-532, issn 0362-5664Article
Efficacité et tolérance du veralipride dans le traitement des bouffées de chaleur de la ménopause: Etude multicentrique = Efficacy and tolerance of veralipride in the treatment of sudden flushes of menopause. A multicentric studyBOUKOBZA, G.Revue française de gynécologie et d'obstétrique. 1986, Vol 81, Num 8, pp 413-417, issn 0035-290XArticle
Dopamine antagonists reduce spontaneous electrical activity in cultured mammalian neurons from ventral mesencephalonHEYER, E. J.Brain research. 1986, Vol 382, Num 2, pp 404-408, issn 0006-8993Article
Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3-benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detectionKILTS, C. D; DEW, K. L; ELY, T. D et al.Journal of chromatography. 1985, Vol 342, Num 2, pp 452-457, issn 0021-9673Article
6-(-2-amino-ethyl) benzoxazolinones: potent dopaminergic antagonistsBRUNET, C; LUYCKX, M; CAZIN, M et al.Acta therapeutica. 1987, Vol 13, Num 2, pp 125-139, issn 0378-0619Article
Inhibition of human neuroblastoma by dopamine antagonistsMCGRATH, P. C; NEIFELD, J. P.Surgery. 1985, Vol 98, Num 2, pp 135-142, issn 0039-6060Article
Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonistsHRUSKA, R. E.Brain research bulletin. 1986, Vol 16, Num 3, pp 331-339, issn 0361-9230Article
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in miceHEIKKILA, R. E; MANZINO, L; CABBAT, F. S et al.Neuroscience letters. 1985, Vol 58, Num 1, pp 133-137, issn 0304-3940Article
High-performance liquid chromatographic determination of a new benzamide in biological fluids for use in a human pharmacokinetic studyBRESSOLLE, F; BRES, J; SNOUSSI, M et al.Journal of chromatography. 1985, Vol 343, Num 2, pp 443-448, issn 0021-9673Article
Postoperative neurologic dysfunction associated with preoperative administration of metoclopramideSCHELLER, M. S; SEARS, K. L.Anesthesia and analgesia. 1987, Vol 66, Num 3, pp 274-276, issn 0003-2999Article
Analgesic effect of metoclopramide and its mechanismRAMASWAMY, S; BAPNA, J. S.Life sciences (1973). 1986, Vol 38, Num 14, pp 1289-1292, issn 0024-3205Article
Different effects of metoclopramide and domperidone on arginine-vasopressin secretion in manCHIODERA, P; VOLPI, R; DELSIGNORE, R et al.British journal of clinical pharmacology. 1986, Vol 22, Num 4, pp 479-482, issn 0306-5251Article
A novel long-lasting dopamine receptor blocker: haloperidol-bovine serum albumin conjugateGARRIGUES, A.-M; STINUS, L; TAGHZOUTI, K et al.European journal of pharmacology. 1985, Vol 118, Num 3, pp 313-319, issn 0014-2999Article
Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainARNT, J; CHRISTENSEN, A. V; HYTTEL, J et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 329, Num 2, pp 101-107, issn 0028-1298Article
Potential uses for metoclopramideSHAUGHNESSY, A. F.Drug intelligence & clinical pharmacy. 1985, Vol 19, Num 10, pp 723-728, issn 0012-6578Article
The clinical significance of halopemide, a dopamine-blocker related to the butyrophenonesDE CUYPER, H; VAN PRAAG, H. M; VERSTRAETEN, D et al.Neuropsychobiology. 1984, Vol 12, Num 4, pp 211-216, issn 0302-282XArticle
Effects of dopaminergic agonists and antagonists on the partially contracted, isolated and perfused renal artery of the ratRODRIGUEZ-MENDEZ, S. A; FERIA, M; BOADA, J et al.Pharmacology. 1986, Vol 32, Num 6, pp 321-325, issn 0031-7012Article